Skip to the page

Data / Drug companies / HHH Pharmaceuticals

HHH Pharmaceuticals: 10 products in the FDA NDC directory, labeler code 83586

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

HHH Pharmaceuticals (labeler code 83586) lists 10 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 1, 2026.

The request: Watch HHH Pharmaceuticals (FDA labeler code 83586): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
83586
Products in commercial distribution
10
Packages
11
Finished drugs by generic name
6
Prescription products
0
Over the counter products
10
Flagged as original packager
9 of 9 products that carry the flag
Started marketing in the last 12 months
3
Earliest marketing start
July 23, 2025
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs10100%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated440%
Tablet, delayed release330%
Tablet330%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tension Headache Relief83586-118Tablet, film coatedOver the counter monograph drugsOctober 1, 2026
Bisacodyl83586-012Tablet, delayed releaseOver the counter monograph drugsJuly 2, 2026
Acetaminophen, Diphenhydramine Hydrochloride, and Phenylephrine Hydrochloride83586-004Tablet, film coatedOver the counter monograph drugsJune 27, 2026
Senna with docusate sodium83586-001TabletOver the counter monograph drugsOctober 7, 2025
Phenylephrine hydrochloride83586-010TabletOver the counter monograph drugsSeptember 10, 2025
Pain Reliever83586-107Tablet, film coatedOver the counter monograph drugsAugust 12, 2025
Nasal Decongestant PE83586-160TabletOver the counter monograph drugsJuly 28, 2025
Laxative83586-116Tablet, delayed releaseOver the counter monograph drugsJuly 28, 2025
Extra Strength Aspirin83586-115Tablet, film coatedOver the counter monograph drugsJuly 28, 2025
Aspirin 81mg Enteric Coated83586-104Tablet, delayed releaseOver the counter monograph drugsJuly 23, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.